Beyond symptom reduction: Veterans' goals for posttraumatic stress disorder treatment

Abstract: Despite a varied selection of available trauma-focused evidence-based psychotherapies (TF-EBPs) for posttraumatic stress disorder (PTSD), few veterans receive a full course of an evidence-based treatment. A better understanding of and alignment with veterans' PTSD treatment goals could be one way to improve treatment engagement and adherence, consistent with veteran-oriented care within the U.S. Department of Veterans Affairs (VA) Healthcare System. Few studies have examined veterans' specific goals or reasons for seeking treatment for PTSD. We conducted a qualitative analysis using secondary data from a randomized controlled trial (RCT) of 175 veterans who were randomized to receive a TF-EBP for PTSD. Veterans completed a self-report questionnaire at baseline and were asked to identify three distinct goals for treatment using a short-answer format. Two authors coded the data and identified themes. Three themes were identified: improvements in PTSD symptoms, personal well-being and growth, and improvements in social roles and interpersonal functioning. These findings suggest that veterans with PTSD have both symptom reduction goals and functional goals at the outset of treatment. The findings also emphasize the importance of broadening the scope of treatment outcome monitoring and assessment to better reflect patient-centered care and veterans' specific goals.

Read the full article
Report a problem with this article

Related articles

  • More for Researchers

    Identifying opioid relapse during COVID-19 using natural language processing of nationwide Veterans Health Administration electronic medical record data

    Abstract: Novel and automated means of opioid use and relapse risk detection are needed. Unstructured electronic medical record data, including written progress notes, can be mined for clinically relevant information, including the presence of substance use and relapse-critical markers of risk and recovery from opioid use disorder (OUD). In this study, we used natural language processing (NLP) to automate the extraction of opioid relapses, and the timing of these occurrences, from veteran patients' electronic medical record. We then demonstrated the utility of our NLP tool via analysis of pre-/post-COVID-19 opioid relapse trends among veterans with OUD. For this demonstration, we analyzed data from 107,606 veterans OUD enrolled in Veterans Health Administration, comparing a pandemic-exposed cohort (n = 53,803; January 2019-March 2021) to a matched prepandemic cohort (n = 53,803; October 2017-December 2019). The recall of our NLP tool was 75% and our precision was 94%, demonstrating moderate sensitivity and excellent specificity. Using the NLP tool, we found that the odds of opioid relapse postpandemic onset were proportionally higher compared to prepandemic trends, despite patients having fewer mental health encounters from which to derive instances of relapse postpandemic onset. In this research application of the tool, and as hypothesized, we found that opioid relapse risk was elevated postpandemic. The application of NLP Methods: to identify and monitor relapse risk holds promise for future surveillance, risk prevention, and clinical outcome research.